On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled incredible new data from whole genome sequencing of its half a million participants.

This is set to drive the discovery of new diagnostics, treatments and cures. Uniquely, it is also available to approved researchers worldwide, via a protected database containing only de-identified data (for example, name, address, date of birth, name of GP and more stripped out).

To date, over 30,000 researchers from more than 90 countries have registered to use UK Biobank, with over 9,000 peer-reviewed papers published as a result.